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 Introduction  
 Systemic granulomas develop in re-
sponse to infections like  Mycobacterium 
tuberculosis and  Schistosoma mansoni , to 
foreign material or in the context of non-
infectious diseases like sarcoidosis and 
granulomatosis with polyangiitis (Wegen-
er’s granulomatosis). Cutaneous granulo-
mas with unknown aetiology not related 
to infectious or systemic diseases occur 
uncommonly in various primary immu-
nodeficiencies (PIDs).
 Ataxia telangiectasia (A-T) is caused by 
a mutation in the  A-T Mutated gene, local-
ized on chromosome 11 (11q22–23), and its 
protein is involved in cell cycle control and 
DNA repair  [1] . A-T is characterized by 
progressive cerebellar ataxia, oculocuta-
neous telangiectasia, immunodeficiency, 
predisposition toward malignancy, elevat-
ed   1 -fetoprotein levels, rearrangement of 
chromosome 7 and 14, and increased ra-
diosensitivity. In addition, A-T patients 
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 Abstract 
 Background: Non-infective cutaneous 
granulomas with unknown pathogenesis 
occur in various primary immunodeficien-
cies (PIDs) including ataxia telangiectasia
(A-T).  Objective: To find a common immuno-
logical denominator in these cutaneous 
granulomas.  Methods: The dermatological 
and immunological features of 4 patients 
with A-T and cutaneous granulomas were 
described. The literature on skin granulomas 
in A-T and in other PIDs is reviewed.  Results: 
All 4 A-T patients had progressive granulo-
mas on their limbs and showed decreased 
IgG and IgA concentrations with normal IgM 
levels. They had a marked decrease in B cells 
and naïve T cells coinciding with the appear-
ance of the cutaneous granulomas. Similar 
B- and T-cell abnormalities were described 
in patients with other PIDs with skin granu-
lomas.  Conclusions: We hypothesize that 
the pathogenesis of these skin granulomas 
is related to immune dysregulation of mac-
rophages due to the absence of naïve T cells 
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may display a wide range of humoral and 
cellular immune system abnormalities 
and variable lymphopenia  [2] . Here we de-
scribe 4 A-T patients who developed cuta-
neous granulomas and review the litera-
ture of all (n = 17) reported A-T patients 
with skin granulomas. In addition, we re-
view the literature on cutaneous granulo-
mas in all known other PIDs. Based on
the obtained data we propose that unex-
plained cutaneous granulomas in PID pa-
tients can be considered as a manifestation 
of dysregulation in wound healing and tis-
sue repair explained by the immune de-
fects inherent in these PIDs.
 Patients and Methods 
 In mid-2010 there were 52 patients 
known in the Dutch A-T registry. In all, 
the diagnosis was confirmed by chromo-
somal analysis. Cutaneous granulomas 
developed in 4 (8%) of these 52 patients. 
Unfortunately, 1 patient was lost to follow-
up. In this article, we discuss the 3 Dutch 
A-T patients and include 1 Icelandic A-T 
patient with cutaneous granulomas who 
shared the same immunological profile. 
All 4 patients had truncating mutations in 
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the  ATM  gene ( table 1 ) without ATM ki-
nase activity. We also reviewed the exist-
ing literature on cutaneous granulomata 
in patients with A-T and in patients with 
other PIDs. To this end a search was done 
in PubMed with the MeSH words ‘granu-
loma’, ‘skin’, ‘cutaneous’ and all known 
PIDs as reported by the International 
Union of Immunological Societies Expert 
Committee on Primary Immunodeficien-
cies  [3] . Included were all primary publica-
tions published in English, German and 
French. Ten primary reports were found 
describing cutaneous granulomas in A-T 
 [4–13] and a series of articles reporting 
skin granulomas in other PIDs  [14–26] . 
For common variable immunodeficiency 
(CVID), often associated with granulomas 
in various organs, only the recently pub-
lished article of Ardeniz and Cunning-
ham-Rundles  [23] dealing with skin gran-
ulomas was included.
 Case Reports 
 Patient 1 
 An 8-year-old girl of Moroccan ances-
try presented with a 1-year history of ten-
der lesions on the left leg appearing after a 
fall. It started as an ulcer, which progres-
sively enlarged to involve her entire lower 
leg. She had had a diagnosis of A-T at
2 years of age on the basis of cerebellar 
ataxia, elevated   -fetoprotein, recurrent 
sinopulmonary infections with low IgG, 
deficient IgA ( ! 0.10 g/l) but normal IgM 
(1.18 g/l;  table 1 ). At the time of appearance 
of the granulomas, she had almost ab-
sent CD19+ B cells, extremely low naïve 
(CD3+CD4+C45RA+) T cells and normal 
natural killer (NK) cells in her peripheral 
blood ( table  1 ). Clinical examination re-
vealed multiple tender ulcers on the left 
anterior shin and below her knee. The ul-
cers had irregular ragged edges with clean 
fibrinous bases. The surrounding skin was 
erythematous, atrophic and had surface 
telangiectasia ( fig. 1 ). A biopsy from the le-
sions showed palisading granulomas con-
sisting of histiocytes and polynuclear gi-
ant cells with necrosis. Alcian blue stain, 
Ziehl-Neelsen and periodic acid-Schiff 
stain were negative as were cultures for mi-
cro-organisms. The lesions continued to 
deteriorate despite topical tacrolimus, top-
ical corticosteroids, oral antibiotics, tuber-
culostatics and increment of the dosage of 
intravenous immunoglobulin. Slight im-
provement was noted when she was on oral 
corticosteroids given for her interstitial 
lung disease. She suffered from recurrent 
chest infection and succumbed due to re-
spiratory failure at 14 years of age.
 Patient 2 
 Patient 2, the son of consanguineous 
Dutch parents, was diagnosed as having 
Table 1. I mmunological characteristics of the 4 described A-T patients with skin granulomas at the time of diagnosis of A-T and of 
granulomas
Normal value Patient 1 Patient 2 Patient 3 Patient 4
At the time of diagnosis of A-T
Age, months 24 24 12 24
Mutation c.2921+5G]A c.2467+1551 del 97kb c.5188C]T c.2554C]T
IgG, g/l 4.0–11.0 2.27 2.34 0.50 0.30
IgA, g/l 0.1–1.80 <0.10 <0.10 <0.10 <0.10
IgM, g/l 0.5–1.80 1.18 1.93 0.90 0.83
CD19+ B cells, !109/l 9–15 months: 0.6–2.7 
15–24 months: 0.6–3.1
0.4 0.16 0.16 0.07
CD3+ T cells, !109/l 9–15 months: 1.6–6.7
15–24 months: 1.4–8.0
1.6 0.83 1.04 0.68
CD4+ T cells, !109/l 9–15 months: 1.0–4.6
15–24 months: 0.9–5.5
1.0 0.72 0.45 0.30
Naïve CD4+ T cells, !109/l 0.4 0.10 0.02 not available
Effector CD4+ T cells, !109/l 1.0 0.57 0.40 not available
CD8+ T cells, !109/l 9–15 months: 1.0–4.6
15–24 months: 0.9–5.5
1.2 0.21 0.21 0.56
NK cells, !109/l 9–15 months: 0.2–1.2
15–24 months: 0.1–1.4
1.1 0.15 0.50 0.51
At the time of diagnosis of granulomas
Age, years 8 8 7 8
B cells, !109/l 0.2–1.6 0.01 0.03 0.07 0.01
CD3+ T cells, !109/l 0.7–4.2 0.34 0.90 1.50 0.65
CD4+ T cells, !109/l 0.3–2.0 0.28 0.70 0.50 0.31
Naïve T cells, !109/l 0.03 0.02 <0.01 <0.01
Effector T cells, !109/l 0.24 0.68 0.24 0.15
CD8+ T cells, !109/l 0.3–2.0 0.24 0.13 0.43 0.31
NK cells, !109/l                                   0.09–0.9 0.33 0.04 0.36 0.41
 T cells, !109/l                                 0.06–0.6 0.02 0.11 0.05 0.61
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A-T at the age of 2 years based on cerebel-
lar ataxia, ocular telangiectasia, recurrent 
upper respiratory tract infections and low 
IgG, absent IgA and slightly increased IgM 
(1.93 g/l;  table 1 ). At the age of 6 years he 
developed progressive lesions on the arms 
and legs. Clinical examination at 8 years 
old showed erythematous atrophic plaques 
on his right hand and left leg associated 
with surface telangiectasia ( fig.  2 ) and 
shallow tender ulcers on his right wrist 
and left foot. At that time, he had mark-
edly decreased CD19+ B cells, low 
CD3+CD4+CD45RA+ naïve T cells and 
low but detectable NK cells in his periph-
eral blood ( table 1 ). On histology, granulo-
matous inflammation was seen in the 
deeper half of the dermis consisting of ep-
ithelioid histiocytes and polynuclear giant 
cells surrounding a necrotic centre. Small 
amounts of mucin were demonstrated in 
the centre of the granuloma. Culture for 
micro-organisms, Ziehl-Neelsen stain and 
periodic acid-Schiff stain were negative. 
The histological and immunohistochemi-
cal features of his granulomas were pub-
lished previously  [27] . Notably, the intra-
lesional CD4+/CD8+ ratio was low (0.28). 
The lesions did not respond to topical or 
intralesional corticosteroids or topical and 
systemic antibiotics. Although some im-
provement was noted with topical tacroli-
mus, the plaques on his limbs persisted. At 
the age of 12, he developed a premalignant 
B cell lymphoma which regressed with 
rituximab. Unfortunately, a year later, he 
was discovered to have nasopharyngeal 
carcinoma and passed away.
 Patient 3 
 Patient 3, a girl of Afghan ancestry, was 
diagnosed as having A-T when she was
1 year old on the basis of a positive family 
history (2 siblings had A-T) and investiga-
tions revealing elevated   -fetoprotein, low 
IgG, deficient IgA and normal IgM ( ta-
ble 1 ). At 7 years old, she presented with 2 
discrete well-demarcated plaques on her 
left lower leg, which appeared after an in-
sect bite. Clinical examination showed a 5 
by 2 cm dusky-red, scaly, well-demarcated 
plaque with central crusting on her left 
lower leg and another similar plaque on 
her right forearm. The lesions were not 
tender. At that time, she had almost ab-
sent CD19+ B cells, very low CD3+CD4+
CD45RA+ naïve T cells and normal NK 
cells in her peripheral blood ( table 1 ).
 Patient 4 
 From the age of 6 months, this Icelan-
dic girl suffered from recurrent otitis me-
dia and pneumonia. When she was 16 
months old, immunological investigations 
revealed IgG and IgA deficiency with nor-
mal IgM ( table 1 ). She was started on im-
munoglobulin substitution and prophy-
laxis for  Pneumocystis jirovecii pneumo-
nia. She developed cerebellar ataxia at 18 
months. At 8 years old, she developed, 
without distinct triggers, erythematous 
indurated plaques on her face, thighs and 
legs. The lesions on her face measured be-
tween 0.5 and 4 cm. They were non-tender, 
not ulcerated, erythematous, slightly in-
durated but not fixed to the underlying 
structures. A biopsy showed granuloma-
tous inflammation. Alcian blue, Ziehl-
Neelsen and periodic acid-Schiff stains 
were normal, and repeated cultures and 
polymerase chain reaction for micro-or-
ganisms were negative. At the time of di-
agnosis of the granulomas, she was found 
to have a significantly decreased number 
of CD19+ B cells, low CD4+ T cells but 
normal NK cells in her peripheral blood 
( table 1 ). Treatment including topical and 
intralesional steroids, topical tacrolimus, 
oral antibiotics, oral antifungal agents and 
etanercept were unsuccessful. With oral 
steroids, the granulomas decreased signif-
icantly but relapsed after withdrawal. 
Control of the granulomas was again ob-
tained with reintroduction of steroids that 
were maintained at low doses.
 Review of the Literature 
 We traced in the literature 17 reported 
A-T patients with cutaneous granulomas 
 [4–13] ( table  2 ). There was a female pre-
ponderance (13 females, 4 males) com-
pared with equal sex distribution in A-T 
patients in general. The age at presentation 
of the cutaneous granulomas ranged from 
1.5 to 31 years. The duration of skin lesions 
before diagnosis varied from 11 months to 
5 years. Interestingly, in 4 of the reported 
patients, the onset of granulomas antedat-
ed the diagnosis and the classical cutane-
ous features of A-T. All patients presented 
in the literature, including ours, had le-
sions on the limbs. The second most com-
mon site was the face, while only a quarter 
of the patients had lesions on their trunk.
 In the reported patients, the granulo-
mas were described to be well-defined ery-
thematous indurated papules and plaques, 
which slowly enlarged and became scaly. 
They were usually small, less than 5 cm in 
diameter, though lesions up to 10 cm were 
reported. Most had central atrophy with 
occasional ulceration and surface telangi-
ectasia. The lesions healed with hyperpig-
mentation. Tenderness was noted in 3 of 
the 17 reported patients whereas 2 of our 4 
patients had significant pain.
 Immunoglobulin levels were measured 
in only 8 of the 17 reported patients. Five 
had IgG deficiency; 3 had normal total 
IgG, although in one IgG2 was low (IgG 
subclasses were not measured in the other 
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 Fig. 1. Ulcer on the leg with surrounding 
erythema, atrophy and telangiectasia of 
patient 1. 
 Fig. 2. Erythematous atrophic plaques as-
sociated with telangiectasia on the leg of 
patient 2. 
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2 patients). All 8 patients in whom immu-
noglobulin levels were reported had mark-
edly decreased IgA levels and normal or 
elevated IgM. Only in 1 patient were data 
on B cells, T cells and NK cells available 
 [13] . In this 3-year-old boy, B cell count 
was decreased (0.04  ! 10 9 /l), T cells 
(CD3+) were low (0.30  ! 10 9 /l) with
a marked predominance of T cells
with a memory phenotype (CD3+CD4+
CD45RO+)  [13] , and NK cell numbers 
were normal. Interestingly, T cell rear-
rangement excision circles in this patient 
were extremely low for both CD4+ and 
CD8+ T cells with oligoclonal expansion 
in most peripheral CD4+ and CD8+ T 
cells. Also, the T cell receptor (TCR) rep-
ertoire in the skin biopsy was skewed  [13] .
 No treatment was shown to be effec-
tive. Topical steroids and oral antibiotics 
did not alter the course of the disease 
though topical steroids decreased the ery-
thema and scaling of lesions in 2 patients 
 [4, 5] . Oral steroids in combination with 
oral antibiotics resulted in slow control in 
1 patient in the literature; however, the le-
sions relapsed after cessation of steroids 
 [12] . Similar control and relapse with the 
discontinuation of oral steroids was also 
noted in our fourth patient. Intravenous 
immunoglobulin therapy had no effect in 
3 patients while in another patient, it was 
reported to induce regression of the lesions 
 [7, 11] . Local recurrence and enlargement 
occurred after excision in 1 patient  [5] . 
Paller et al.  [5] proposed a trial of topical 
corticosteroid for granulomas in A-T pa-
tients that are not ulcerated, while applica-
tion of topical mupirocin or non-adherent 
dressings is most appropriate for ulcerated 
lesions. For A-T patients with debilitating 
granulomas, she proposes administration 
of systemic steroids, to be undertaken with 
caution in view of their tendency towards 
progressive sinopulmonary infections.
 Our literature search on the occur-
rence of skin granulomas in other PIDs re-
vealed description of cutaneous granulo-
mas in Nijmegen breakage syndrome 
(NBS)  [14, 15] , severe combined immuno-
deficiency caused by deficiency of recom-
binant activating gene (RAG)  [16] , Arte-
mis  [17] and JAK3  [18] , TAP deficiency 
syndrome  [19–21] , Griscelli syndrome  [22] 
and CVID  [23] ( table 3 ). Three studies on 
skin granulomas were cancelled: 2 studies 
describing lesions in a patient with X-
linked hyper-IgM  [24] and IgA deficiency 
 [25] , because from the decription the le-
sions appeared sarcoid-like not resem-
bling the skin granulomas in A-T, and 1 
study on a man with X-linked agamma-
globulinaemia  [26] because the paper was 
published in 1991 before the  btk  gene anal-
ysis became available and the description 
of the patient did not fit to what is now 
known for X-linked agammaglobulinae-
mia.
 In NBS, a condition caused by a DNA 
repair defect resembling the defect in A-T, 
which is characterized by microcephaly, a 
special face and combined immunodefi-
ciency, 2 patients with skin granulomas 
have been described  [14, 15] . Skin granulo-
mas have been reported also in severe 
combined immunodeficiency caused by 
RAG deficiency  [16] (2 patients), Artemis 
deficiency  [17] (1 patient) or JAK3 defi-
ciency  [18] (1 patient). In Griscelli syn-
drome, characterized by partial pigmen-
tary dilution or albinism, frequent in-
fections and neurological abnormalities, 
defective NK- and T-cell cytotoxicity and 
uncontrolled lymphocyte and macro-
phage activation, 1 patient has been de-
scribed  [22] . In patients with HLA class I 
deficiency (TAP deficiency)  [19–21] and in 
patients with CVID, cutaneous granulo-
mas are reported more frequently. Granu-
lomas in various other organs (lung, liver, 
lymph nodes, gastro-intestinal tract) are a 
well-known feature of the subgroup of 
CVID patients with a defective B cell class 
switch and low T cells  [28] .
 Discussion 
 The principal finding of the current 
study is the observation of non-infectious 
dermal granulomas in A-T patients. A-T is 
a PID associated with defective DNA re-
pair. In B and T cells, this defect causes a 
restricted repertoire of the B cell receptor 
and the TCR  [29] . Approximately 10% of 
A-T patients have a deficiency of IgG and 
IgA and unaffected or even slightly in-
creased IgM levels, which is indicative
of a defective CD4+ Th2-cell-dependent 
switch of B cells in the germinal centre.
All our 4 A-T patients with granulomas 
Table 2. I mmunological characteristics of A-T patients in general and in patients reported in the literature with skin granulomas
Number
of patients
Age
years
IgG IgA IgM IgG2 B cells CD3+
cells
CD3+CD4+
cells
CD3+CD8+
cells

T cells
NK 
cells
A-T (classical) N fff N fff N–f N–f N–f N–f N N
Fleck et al. [4], 1986 1 8 f fff ddd
Paller et al. [5], 1991 8
Joshi et al. [6], 1993 1 7 N fff d
Götz et al. [7], 1994 1 13 N fff d ff d
Drolet et al. [8], 1997 1 6.5 N fff N
Murakawa et al. [9], 1998 1 8
Sentürk et al. [10], 1998 1 12 fff f N
Corbisier et al. [11], 1999 1 2 fff f ddd
Mitra et al. [12], 2005 1 4 f fff fff
Folgori et al. [13], 2010 1 3 ff fff N fff ff f ff f N
N = Normal; d = increased; ddd = markedly increased; f = decreased; ff = moderately decreased; fff = markedly decreased.
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had this hyper-IgM phenotype. Indeed, 
switched memory B cells, determined in 2 
of them, were absent [Driessen et al., in 
preparation]. Further, we noticed that by 
the time of diagnosis of the cutaneous 
granulomas in our A-T patients, they all 
had a markedly reduced number of CD19+ 
B cells and CD3+CD4+CD45RA+ naïve T 
cells ( table 1 ). This immunological profile 
is distinct from that observed in our pa-
tients at an earlier stage and also differs 
from that reported in the literature for A-T 
patients without skin granulomas  [30] . In-
terestingly, the same immunological dis-
turbances were mentioned in the A-T pa-
tient with cutaneous granulomas of Fol-
gori et al.  [13] ( table 1 ) and in the patients 
with cutaneous granulomas associated 
with RAG deficiency  [16] and Artemis de-
ficiency  [17] ( table 2 ). CVID patients, par-
ticularly those with B- and T-cell lympho-
penia and reduced switched memory B 
cells, are also more prone to granuloma-
tous disease  [28, 31] . Resolution of cutane-
ous granulomas in RAG deficiency and 
Artemis deficiency have been noted after 
haematopoietic stem cell transplantation 
 [16, 17] .
 In none of the A-T patients with skin 
granulomas was an infective cause dem-
onstrated. Cultures and staining for mi-
cro-organisms in all 17 reported patients 
as well as in all our 4 patients were nega-
tive. In several patients, the granulomas 
developed after minor injuries. The pro-
pensity for granulomas to appear on the 
limbs (trauma-prone area) may be related 
to impaired wound healing and tissue re-
pair in these immunodeficient patients. 
The marked decrease in B cells and naïve 
T cells in our A-T patients coinciding with 
the appearance of the cutaneous granulo-
mas ( table 1 ) suggests that the immunopa-
thology of these skin lesions may be sec-
ondary to impaired B-cell- or T-cell-medi-
ated immune regulation.
 Dermal wound healing is a complex se-
quential process that involves the integra-
tion of chemotaxis of inflammatory cells, 
migration of keratinocytes and remodel-
ling of scar tissue. T cells, B cells and vari-
ous key growth factors and enzymes work 
in synergy to orchestrate the healing pro-
cess  [32] . CD19 is a positive-response regu-
lator of B cells, which plays a critical role in 
wound healing as is shown by the observa-
tion that CD19 deficiency in mice inhibits 
wound healing  [33] . Macrophages exert 
different roles at diverse stages of the re-
pair response, and they orchestrate the 
 Table 3.  Immunological characteristics of patients with other PIDs and skin granulomas 
PID Number
of patients
Age
years
IgG IgA IgM IgG2 B cells CD3+
cells
CD3+CD4+
cells
CD3+CD8+
cells
γδ T 
cells
NK 
cells
NBS N–f fff N fff N–f N–f N–f N–f N N
Yoo et al. [14], 2008 1  7 N fff f f
Vogel et al. [15], 2010 1  9 fff fff fff f
RAG deficiency fff fff fff fff fff fff fff fff N N
Schuetz et al. [16], 2008 2  3 fff ff ff fff fff fff f N N
 7 fff ff N ff ff ff low N N N
Artemis deficiency fff fff fff fff fff fff fff fff N N
IJspeert et al. [17], 2011 1  6 N–f ff f ff f f N N N
 Jak3 deficiency f f f N–d ff fff–f
Gregoriou et al. [18], 2008 1  6 fff fff f fff N fff
HLA class I deficiency (TAP deficiency) N N N N N f
Moins-Teisserenc et al. [19], 1999 5 adult N ff dd dd
adult f N d dd
adult ff dd d d
27 f N d dd
36 f f dd dd
Mertens et al. [20], 2000 1 34 ff d
Villa Forte et al. [21], 2008 1 20 N f d N
Griscelli syndrome N N N N N abnormal
Eyer et al. [22], 1998 1  3
Common variable immunodeficiency ff N–fff N–fff ff N–ff N–ff N–ff N N
Ardeniz and Cunningham-Rundles 
[23], 2009 7 14 fff fff fff N
16 fff fff f ff
22 f fff fff fff
27 fff fff fff f
37 fff fff f ff
44 f f N
59 fff fff f f
N = Normal; d = increased; dd = moderately increased; ddd = markedly increased; f = decreased; ff = moderately decreased; fff = markedly decreased.
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natural sequence of repair phases in skin, 
which are essential to restore solid tissue 
homeostasis and integrity after injury  [34] . 
Macrophages are activated in response to 
various cytokines, including interferon-  
(IFN-  )  [35] that is produced by NK cells 
 [36] and by T cells. The crucial role of IFN-
  in the induction of granulomas is illus-
trated by the inability of patients with a de-
fective IFN-  signalling pathway to form 
mature granulomas in response to myco-
bacterial infections  [37] . The importance 
of NK cells is illustrated by the occurrence 
of granulomas in patients with TAP defi-
ciency who lack, by the absence of HLA 
class I molecules, the ability to turn off NK 
cell activity and thus NK-cell-derived 
IFN-  production  [19, 38] . In A-T patients, 
the amount of intracellular IFN-  in NK 
cells is not different from controls  [30] , and 
NK cell numbers were normal in our A-T 
patients and also in patients with RAG de-
ficiency and Artemis deficiency ( table  1 
and  2 ). However, in the patient with JAK3 
deficiency and granulomas, NK cells were 
absent.
 An appropriate on-off T cell response 
requires proliferation of naïve T cells with 
a normal, unrestricted TCR repertoire 
 [39] . In A-T, the TCR repertoire is skewed 
as it was in the patient with skin granulo-
mas reported by Folgori et al.  [13] . Simi-
larly, an abnormal TCR repertoire has 
been reported in the patients with RAG 
deficiency and in patients with CVID who 
display granulomas. Specific CD4+ Th1 
lymphocytes recognize, via their    TCR 
complex, peptide antigens presented by 
macrophages on major histocompatibility 
class II molecules  [40] . Although most T 
cells bear the TCR    complex, a small 
subpopulation of about 5% have a distinct 
TCR composed of   - and   -subunits. For 
non-peptide antigens, as encountered in 
 Mycobacterium infections, IFN-  comes 
mainly from these    T cells which recog-
nize antigens that are not presented in the 
major histocompatibility class II context 
 [41] . T cells bearing    -receptors are pres-
ent in patients with A-T  [42] , NBS, RAG 
deficiency and Artemis deficiency. In the 
patient with JAK3 deficiency and skin 
granulomas, the presence of    T cells was 
not investigated; however,    T cells were 
demonstrated in other patients with this 
defect  [43] . In patients with TAP deficien-
cy,    T cells are elevated, and autoreactive 
NK and    T cells were demonstrated  [38] . 
Both NK cells and    T cells have been re-
ported to be important in the development 
of cutaneous granulomas  [37, 38, 40, 44–
46] .
 IL-10 is a cytokine, derived from Th2 
cells, that inhibits Th1-derived IFN-  pro-
duction  [47, 48] . Thus, whereas granuloma 
induction requires IFN-  , the resolution 
of granulomas needs IL-10. This means 
that appropriate activation of both specific 
Th1 cells and Th2 cells is crucial for an ap-
propriate induction and cessation of a 
granulomatous response.
 We propose that in patients with im-
munodeficiencies like A-T, NBS, deficien-
cies of RAG, Artemis and CVID, macro-
phages cannot function appropriately due 
to the lack of naïve (CD4+CD45RA+) T 
cells with a functional unrestricted TCR 
repertoire on CD4+ Th1 and Th2 cells. 
Whereas NK cells and/or    T cells will 
continue to activate the macrophages in 
the skin, this activation cannot be down-
regulated due to the absence of a counter-
regulatory IL-10 production by a specific 
CD4+ cell population.
 In conclusion, we report that a subset of 
A-T patients with deficiencies of IgG, IgA 
and normal or even increased levels of IgM 
(the so-called hyper-IgM phenotype) is 
more likely to develop cutaneous granulo-
mas. We postulate that the aetiology of 
these granulomas is related to immune 
dysregulation as suggested by a marked re-
duction of peripheral CD19+ B cells, a low 
number of CD3+CD4+CD45RA+ naïve T 
cells in the presence of normal NK cells 
and    T cells.
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